首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1759009

全球硬腦膜移植市場

Dural Graft

出版日期: 2025年06月30日 | 出版商:

Global Industry Analysts, Inc. | 英文 499 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球硬腦膜移植市場規模將達 11 億美元

全球硬腦膜移植市場規模預計在2024年為8.135億美元，預計到2030年將達到11億美元，在2024-2030年的分析期內，複合年成長率為4.5%。異種移植硬腦膜是本報告分析的細分市場之一，預計其複合年成長率為4.4%，到分析期結束時市場規模將達到3.419億美元。同種異體硬腦膜移植市場在分析期間的複合年成長率預計為5.1%。

美國市場規模將達 2.216 億美元；中國市場預期複合年成長率為 8.1%

預計2024年美國硬腦膜移植市場規模將達2.216億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到2.181億美元，在2024-2030年的分析期內，複合年成長率為8.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為1.9%和3.5%。在歐洲，預計德國市場的複合年成長率為2.6%。

全球硬腦膜移植市場—主要趨勢與促進因素摘要

醫學界引進硬腦膜移植的動力是什麼？

硬腦膜移植已成為神經外科和脊椎外科的基石，特別是在涉及硬腦膜斷裂、顱骨減壓手術和脊椎硬腦膜成形術的病例中。這些移植物是硬腦膜（包覆大腦和脊髓的保護膜）的重要補片或替代品。創傷性腦損傷、脊髓損傷和神經外科手術的發生率不斷上升，對可靠的硬腦膜修復材料的需求也越來越大。隨著人們對腦脊髓液 (CSF) 漏等術後併發症的認知不斷提高，有效閉合硬腦膜的重要性從未被強調。外科醫生現在優先考慮不僅能作為功能屏障，而且還能與原生組織良好結合的移植物，促進癒合並降低感染和粘連的風險。旨在改善手術結果和減少併發症的醫療保健系統的轉變在加速全球採用先進的硬腦膜移植材料方面發揮關鍵作用。

材料創新如何改變植入物的功能？

硬腦膜移植市場最重要的發展之一是生物材料的演變。最初，從患者自身體內採集的自體移植被認為是黃金標準，但其局限性（例如供體部位發病率和手術時間延長）促使合成和異質骨移植替代品的開發。現今的硬腦膜移植包括基於膠原蛋白的異質骨移植（通常來自牛或豬）、聚氨酯和發泡聚四氟乙烯 (ePTFE) 等合成聚合物以及混合生物工程材料。這些材料具有優異的生物相容性、抗張強度和防水密封能力，並且通常具有其他優勢，例如抗炎塗層和可控的分解時間。有些材料還具有支架結構，可促進自體細胞生長和組織再生。此外，無縫線和密封劑相容的移植材料顯著提高了手術的便利性和速度。這些技術改進不僅使手術更加高效，而且還降低了腦脊髓液洩漏和感染的風險，而這些都是臨床決策的關鍵因素。

為什麼地方醫療系統會加速使用貪污賄賂？

受醫療基礎設施、監管核准流程和手術量的影響，不同地區的硬腦膜移植應用呈現不同的趨勢。北美和歐洲憑藉其強大的神經外科網路、較高的手術量和優惠的報銷制度，在應用方面處於領先地位。這些地區也更容易獲得優質的移植材料，臨床醫生偏好有實證依據的產品。同時，亞太地區的需求正在激增，這得益於醫療涵蓋範圍的擴大、對手術品質的認知的提高以及創傷相關神經外科病例的增加。此外，印度和中國等國家的三級醫院和專科醫院的手術能力正在快速提升，這推動了先進硬腦膜修復產品的普及。在拉丁美洲以及中東和非洲部分地區，市場成長尚處於相對起步階段，但隨著全球醫療科技公司擴大業務範圍並推出針對新興市場的經濟高效的移植解決方案，市場成長勢頭正在增強。這種市場多元化正在拓展整體市場潛力，並鼓勵更廣泛地接受硬腦膜移植技術。

推動硬腦膜移植市場成長軌跡的因素是什麼？

硬腦膜移植市場的成長受多種因素驅動。其中最主要的是全球神經外科和脊椎外科手術數量的不斷成長，這些手術需要有效的硬腦膜修復解決方案。移植材料設計的創新，例如更高的生物相容性、更低的發炎反應以及對組織再生的支持，正在增強外科醫生的信心並改善臨床療效。向微創手術的轉變也有利於在更狹窄的手術通道中快速可靠地植入先進的移植材料。此外，對腦脊髓液 (CSF) 相關併發症的認知不斷提高，以及具有卓越密封性能的移植材料的供應，正在降低術後發病率，進一步推動其應用。新產品的監管核准以及移植臨床適應症的不斷擴大，使得這些設備在已開發經濟體和新興經濟體的醫療保健系統中更容易獲得。對患者復健指標、再入院率和長期療效的日益關注，也鼓勵醫療保健機構投資可靠且成熟的移植技術。這些因素共同推動全球硬腦膜移植市場進入持續加速成長階段。

部分

產品（國外主題詞、同源主題詞、合成主題詞、自體主題詞、其他產品）、材料（牛材料、屍體硬腦膜材料、自體心包材料、合成牛膠原蛋白基質材料、硬腦膜材料、其他材料）、應用（腦外傷及脊髓損傷應用、腦血管疾病應用、腦脊髓液儲存應用、腦部及脊髓腫瘤應用、癲癇應用、其他應用）、最終用途（醫院最終用途、門診手術中心最終用途、創傷中心最終用途、診所最終用途）

受訪公司範例（43家值得關注的公司）

Acera Surgical
Aesculap, Inc.（B. Braun）
Baxter International Inc.
Beijing TianXinFu Medical Appliance
B. Braun Melsungen AG
Collagen Matrix, Inc.
Cook Medical
Cousin Biotech
Guanhao Biotech
Gunze Limited
Integra LifeSciences Corporation
Johnson & Johnson（DePuy Synthes）
LeMaitre Vascular
Medprine
Medtronic plc
Natus Medical Incorporated
Nurami Medical
Stryker Corporation
Tissuemed Ltd
WL Gore & Associates

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

The global market for Dural Graft estimated at US$813.5 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Xenogeneic Dural Graft, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$341.9 Million by the end of the analysis period. Growth in the Allogenic Dural Graft segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$221.6 Million While China is Forecast to Grow at 8.1% CAGR

The Dural Graft market in the U.S. is estimated at US$221.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$218.1 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Dural Graft Market - Key Trends & Drivers Summarized

What’s Driving the Medical Community Toward Dural Graft Adoption?

Dural grafts have become a cornerstone in neurosurgical and spinal procedures, especially in cases involving dural tears, cranial decompression, and spinal duraplasty. These grafts serve as critical patches or substitutes for the dura mater-the protective membrane surrounding the brain and spinal cord-especially when the native dura is damaged or removed. The rising incidence of traumatic brain injuries, spinal disorders, and neurosurgical interventions has created a robust demand for reliable dural repair materials. As awareness of postoperative complications such as cerebrospinal fluid (CSF) leaks grows, the importance of effective dural closure has never been more emphasized. Surgeons now prioritize grafts that not only serve a functional barrier but also integrate well with native tissue, promote healing, and reduce the risk of infection or adhesion. The healthcare system’s shift toward improving surgical outcomes and minimizing complications is playing a critical role in accelerating the adoption of advanced dural graft materials across the globe.

How Are Material Innovations Transforming Graft Functionality?

One of the most significant developments in the dural graft market lies in the evolution of biomaterials. Originally, autologous grafts taken from the patient's own body were considered the gold standard, but their limitations-such as donor site morbidity and extended surgery time-spurred the development of synthetic and xenogeneic alternatives. Today’s dural grafts include collagen-based xenografts (typically derived from bovine or porcine sources), synthetic polymers like polyurethane or expanded polytetrafluoroethylene (ePTFE), and hybrid bioengineered materials. These offer excellent biocompatibility, tensile strength, and watertight sealing capabilities, often with added benefits such as anti-inflammatory coatings or controlled degradation timelines. Some are also engineered with scaffold structures that encourage native cell proliferation and tissue regeneration. Furthermore, sutureless grafts and sealant-compatible grafts have significantly improved procedural ease and speed. These technological enhancements not only make surgeries more efficient but also reduce the risk of CSF leaks and infection, key factors in clinical decision-making.

Why Are Regional Healthcare Systems Accelerating Graft Usage?

Different geographic regions exhibit varied dynamics in dural graft adoption, driven by healthcare infrastructure, regulatory approval processes, and surgical volumes. North America and Europe lead in usage, supported by strong neurosurgical networks, high procedural volumes, and favorable reimbursement frameworks. In these regions, there is greater availability of premium graft materials and stronger clinician preference for evidence-backed products. Asia-Pacific, on the other hand, is experiencing a surge in demand driven by expanding healthcare access, growing awareness about surgical quality, and increasing incidences of trauma-related neurosurgical cases. Moreover, countries like India and China are seeing a rapid upscaling in surgical capabilities in tertiary and specialty hospitals, thus encouraging adoption of advanced dural repair products. In Latin America and parts of the Middle East and Africa, market growth is comparatively nascent but gaining momentum as global medtech companies expand their presence and introduce cost-effective graft solutions tailored for emerging markets. This geographic diversification is broadening the overall market potential and ensuring a more widespread acceptance of dural graft technologies.

What Is Fueling the Growth Trajectory of the Dural Graft Market?

The growth in the dural graft market is driven by several factors. Foremost is the rising global volume of neurosurgical and spinal surgeries, necessitating effective dural repair solutions. Innovations in graft material design-such as enhanced biocompatibility, reduced inflammatory response, and support for tissue regeneration-are increasing surgeon confidence and clinical outcomes. The shift toward minimally invasive procedures also favors advanced grafts that can be deployed quickly and reliably through smaller surgical corridors. Additionally, heightened awareness of CSF-related complications and the availability of grafts with superior sealing capabilities are reducing postoperative morbidity, further boosting adoption. Regulatory approvals for new products and expanding clinical indications for graft use are making these devices more accessible in both developed and emerging healthcare systems. The rising emphasis on patient recovery metrics, hospital readmission rates, and long-term outcomes is also pushing institutions to invest in reliable and proven graft technologies. Together, these factors are propelling the global dural graft market into a phase of sustained and accelerated growth.

SCOPE OF STUDY:

The report analyzes the Dural Graft market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft, Other Products); Material (Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material, Synthetic Bovine Collagen Matrix Material, Ligamentum Nuchae Material, Other Materials); Application (Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use, Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

Acera Surgical
Aesculap, Inc. (B. Braun)
Baxter International Inc.
Beijing TianXinFu Medical Appliance
B. Braun Melsungen AG
Collagen Matrix, Inc.
Cook Medical
Cousin Biotech
Guanhao Biotech
Gunze Limited
Integra LifeSciences Corporation
Johnson & Johnson (DePuy Synthes)
LeMaitre Vascular
Medprine
Medtronic plc
Natus Medical Incorporated
Nurami Medical
Stryker Corporation
Tissuemed Ltd
WL Gore & Associates

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Dural Graft - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rise in Neurosurgical Procedures and Spinal Surgeries Drives Demand for Dural Graft Products
- Growing Geriatric Population Expands Addressable Market for Dural Repair Solutions
- Technological Advancements in Synthetic Grafts Propel Adoption Over Autografts
- Increase in Minimally Invasive Neurosurgeries Generates Demand for Advanced Biomaterials
- Enhanced Biocompatibility and Reduced Infection Rates Strengthen Business Case for Next-Gen Grafts
- Government Investment in Neurotrauma and Brain Injury Treatments Spurs Market Development
- Shift Toward Regenerative Medicine and Tissue Engineering Drives Innovation in Dural Grafts
- Clinical Success and Outcome-Based Reimbursements Accelerate Use of Premium Products
- Surge in Cranial and Spinal Trauma Cases Globally Generates Continuous Product Demand
- Growing Focus on Postoperative Outcomes Throws the Spotlight on Durable and Absorbable Grafts
- Strategic Hospital Procurement Trends Favor Multi-Functional, Long Shelf-Life Graft Options
- Customization and Surgeon-Specific Preferences Drive Adoption of Tailored Graft Sizes
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Dural Graft Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 4: World 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Xenogeneic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Xenogeneic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 7: World 16-Year Perspective for Xenogeneic Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Allogenic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Allogenic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 10: World 16-Year Perspective for Allogenic Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Synthetic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Synthetic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 13: World 16-Year Perspective for Synthetic Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Autologous Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Autologous Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 16: World 16-Year Perspective for Autologous Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Ligamentum Nuchae Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Ligamentum Nuchae Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 22: World 16-Year Perspective for Ligamentum Nuchae Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 25: World 16-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Bovine Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Bovine Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 28: World 16-Year Perspective for Bovine Pericardium Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Cadaveric Dura Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Cadaveric Dura Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 31: World 16-Year Perspective for Cadaveric Dura Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Autologous Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Autologous Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 34: World 16-Year Perspective for Autologous Pericardium Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Synthetic Bovine Collagen Matrix Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Synthetic Bovine Collagen Matrix Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 37: World 16-Year Perspective for Synthetic Bovine Collagen Matrix Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Traumatic Brain & Spine Injury Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Traumatic Brain & Spine Injury Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 40: World 16-Year Perspective for Traumatic Brain & Spine Injury Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 41: World Recent Past, Current & Future Analysis for Cerebrovascular Accident Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 42: World Historic Review for Cerebrovascular Accident Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 43: World 16-Year Perspective for Cerebrovascular Accident Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 44: World Recent Past, Current & Future Analysis for Cerebrospinal Fluid Accumulation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 45: World Historic Review for Cerebrospinal Fluid Accumulation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 46: World 16-Year Perspective for Cerebrospinal Fluid Accumulation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 47: World Recent Past, Current & Future Analysis for Brain & Spine Tumor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 48: World Historic Review for Brain & Spine Tumor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 49: World 16-Year Perspective for Brain & Spine Tumor Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 50: World Recent Past, Current & Future Analysis for Epilepsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 51: World Historic Review for Epilepsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 52: World 16-Year Perspective for Epilepsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 53: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 54: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 55: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 56: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 57: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 58: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 59: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 60: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 61: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 62: World Recent Past, Current & Future Analysis for Trauma Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 63: World Historic Review for Trauma Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 64: World 16-Year Perspective for Trauma Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 65: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 66: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 67: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 68: USA Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: USA Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 70: USA 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 71: USA Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: USA Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 73: USA 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 74: USA Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: USA Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 76: USA 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 77: USA Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: USA Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 79: USA 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
CANADA
- TABLE 80: Canada Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: Canada Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 82: Canada 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 83: Canada Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: Canada Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 85: Canada 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 86: Canada Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: Canada Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 88: Canada 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 89: Canada Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: Canada Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 91: Canada 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
JAPAN
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 92: Japan Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Japan Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 94: Japan 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 95: Japan Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Japan Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 97: Japan 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 98: Japan Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Japan Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 100: Japan 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 101: Japan Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Japan Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 103: Japan 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
CHINA
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 104: China Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: China Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 106: China 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 107: China Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: China Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 109: China 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 110: China Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: China Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 112: China 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 113: China Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: China Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 115: China 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
EUROPE
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 116: Europe Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 117: Europe Historic Review for Dural Graft by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 118: Europe 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
- TABLE 119: Europe Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: Europe Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 121: Europe 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 122: Europe Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: Europe Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 124: Europe 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 125: Europe Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Europe Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 127: Europe 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 128: Europe Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Europe Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 130: Europe 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
FRANCE
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 131: France Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: France Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 133: France 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 134: France Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: France Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 136: France 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 137: France Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: France Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 139: France 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 140: France Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: France Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 142: France 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
GERMANY
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 143: Germany Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 144: Germany Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 145: Germany 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 146: Germany Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Germany Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 148: Germany 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 149: Germany Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Germany Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 151: Germany 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 152: Germany Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 153: Germany Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 154: Germany 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
ITALY
- TABLE 155: Italy Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Italy Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 157: Italy 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 158: Italy Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Italy Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 160: Italy 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 161: Italy Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Italy Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 163: Italy 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 164: Italy Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: Italy Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 166: Italy 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
UNITED KINGDOM
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 167: UK Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: UK Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 169: UK 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 170: UK Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: UK Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 172: UK 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 173: UK Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: UK Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 175: UK 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 176: UK Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: UK Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 178: UK 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
SPAIN
- TABLE 179: Spain Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: Spain Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 181: Spain 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 182: Spain Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: Spain Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 184: Spain 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 185: Spain Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: Spain Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 187: Spain 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 188: Spain Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: Spain Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 190: Spain 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
RUSSIA
- TABLE 191: Russia Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 192: Russia Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 193: Russia 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 194: Russia Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: Russia Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 196: Russia 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 197: Russia Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 198: Russia Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 199: Russia 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 200: Russia Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 201: Russia Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 202: Russia 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
REST OF EUROPE
- TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Rest of Europe Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 205: Rest of Europe 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Rest of Europe Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 208: Rest of Europe 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: Rest of Europe Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 211: Rest of Europe 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 212: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 213: Rest of Europe Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 214: Rest of Europe 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
ASIA-PACIFIC
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 216: Asia-Pacific Historic Review for Dural Graft by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 217: Asia-Pacific 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
- TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 219: Asia-Pacific Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 220: Asia-Pacific 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 222: Asia-Pacific Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 223: Asia-Pacific 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 225: Asia-Pacific Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 226: Asia-Pacific 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 227: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 228: Asia-Pacific Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 229: Asia-Pacific 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
AUSTRALIA
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 230: Australia Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 231: Australia Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 232: Australia 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 233: Australia Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 234: Australia Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 235: Australia 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 236: Australia Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 237: Australia Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 238: Australia 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 239: Australia Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 240: Australia Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 241: Australia 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
INDIA
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 242: India Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 243: India Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 244: India 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 245: India Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 246: India Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 247: India 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 248: India Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 249: India Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 250: India 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 251: India Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 252: India Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 253: India 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
SOUTH KOREA
- TABLE 254: South Korea Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 255: South Korea Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 256: South Korea 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 257: South Korea Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 258: South Korea Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 259: South Korea 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 260: South Korea Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 261: South Korea Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 262: South Korea 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 263: South Korea Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 264: South Korea Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 265: South Korea 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 267: Rest of Asia-Pacific Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 270: Rest of Asia-Pacific Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 271: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 273: Rest of Asia-Pacific Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 274: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 275: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 276: Rest of Asia-Pacific Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 277: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
LATIN AMERICA
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 278: Latin America Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 279: Latin America Historic Review for Dural Graft by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 280: Latin America 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
- TABLE 281: Latin America Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 282: Latin America Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 283: Latin America 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 284: Latin America Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 285: Latin America Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 286: Latin America 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 287: Latin America Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 288: Latin America Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 289: Latin America 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 290: Latin America Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 291: Latin America Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 292: Latin America 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
ARGENTINA
- TABLE 293: Argentina Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 294: Argentina Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 295: Argentina 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 296: Argentina Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 297: Argentina Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 298: Argentina 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 299: Argentina Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 300: Argentina Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 301: Argentina 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 302: Argentina Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 303: Argentina Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 304: Argentina 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
BRAZIL
- TABLE 305: Brazil Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 306: Brazil Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 307: Brazil 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 308: Brazil Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 309: Brazil Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 310: Brazil 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 311: Brazil Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 312: Brazil Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 313: Brazil 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 314: Brazil Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 315: Brazil Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 316: Brazil 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
MEXICO
- TABLE 317: Mexico Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 318: Mexico Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 319: Mexico 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 320: Mexico Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 321: Mexico Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 322: Mexico 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 323: Mexico Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 324: Mexico Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 325: Mexico 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 326: Mexico Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 327: Mexico Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 328: Mexico 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 330: Rest of Latin America Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 331: Rest of Latin America 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 333: Rest of Latin America Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 334: Rest of Latin America 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 336: Rest of Latin America Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 337: Rest of Latin America 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 338: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 339: Rest of Latin America Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 340: Rest of Latin America 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
MIDDLE EAST
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 341: Middle East Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 342: Middle East Historic Review for Dural Graft by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 343: Middle East 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
- TABLE 344: Middle East Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 345: Middle East Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 346: Middle East 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 347: Middle East Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 348: Middle East Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 349: Middle East 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 350: Middle East Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 351: Middle East Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 352: Middle East 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 353: Middle East Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 354: Middle East Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 355: Middle East 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
IRAN
- TABLE 356: Iran Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 357: Iran Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 358: Iran 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 359: Iran Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 360: Iran Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 361: Iran 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 362: Iran Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 363: Iran Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 364: Iran 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 365: Iran Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 366: Iran Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 367: Iran 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
ISRAEL
- TABLE 368: Israel Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 369: Israel Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 370: Israel 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 371: Israel Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 372: Israel Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 373: Israel 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 374: Israel Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 375: Israel Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 376: Israel 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 377: Israel Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 378: Israel Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 379: Israel 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
SAUDI ARABIA
- TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 381: Saudi Arabia Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 382: Saudi Arabia 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 384: Saudi Arabia Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 385: Saudi Arabia 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 387: Saudi Arabia Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 388: Saudi Arabia 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 389: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 390: Saudi Arabia Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 391: Saudi Arabia 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 392: UAE Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 393: UAE Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 394: UAE 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 395: UAE Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 396: UAE Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 397: UAE 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 398: UAE Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 399: UAE Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 400: UAE 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 401: UAE Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 402: UAE Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 403: UAE 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 405: Rest of Middle East Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 406: Rest of Middle East 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 408: Rest of Middle East Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 409: Rest of Middle East 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 411: Rest of Middle East Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 412: Rest of Middle East 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 413: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 414: Rest of Middle East Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 415: Rest of Middle East 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
AFRICA
- Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 416: Africa Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 417: Africa Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 418: Africa 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
- TABLE 419: Africa Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 420: Africa Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 421: Africa 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
- TABLE 422: Africa Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 423: Africa Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 424: Africa 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 425: Africa Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 426: Africa Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 427: Africa 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030